A Review of Terminalia arjuna Effective in Treatment of Cardiovascular Disorder
A. Sharma, Dinesh Kumar, Pooja Sharma
{"title":"A Review of Terminalia arjuna Effective in Treatment of Cardiovascular Disorder","authors":"A. Sharma, Dinesh Kumar, Pooja Sharma","doi":"10.35652/igjps.2019.92s34","DOIUrl":null,"url":null,"abstract":"Cardiovascular diseases have become the leading cause of mortality in India. The epidemiological studies suggest that the ischaemia in cardiac muscle, stroke are the major causes and responsible for >80% of cardiovascular deaths. The Global Burden of disease study estimates of age standardized cardiovascular disease death rate of 272 per 10000 population in India is higher than its global average of 235 per 100000 population. Herbal medicine are also potent medicinal agents like synthetic drugs and are considered to be less toxic and having less side effect in contrast to synthetic drugs. The ultimate norm for any medicine is their specificity, stability, potency, non-toxicity, and efficacy. Terminalia arjuna is one of the most accepted and beneficial plant in indigenous system of medicine. Bark decoction of Terminalia Arjuna is used as a cardioprotective and cardiotonic in angina pectoris, poor blood circulation and for symptomatic relief in high blood pressure.The bark extract contains acids (arjunolic acid, terminic acid), glycosides (arjunetin, arjunosides 1,4) and strong antioxidants flavones, tannins, oligomeric proanthocyanodins. Both of the studies, experimental and clinical, have suggested that the crude drug possesses hypolipidemic, anti-atherogenic activities, anti-ischemic and antioxidant activity. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Sharma; A.; Kumar, D.; Sharma, P. A Review of Terminalia arjuna Effective in Treatment of Cardiovascular Disorders. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 136. DOI: http://doi.org/10.35652/IGJPS.2019.92S34 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"321 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indo Global Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35652/igjps.2019.92s34","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Cardiovascular diseases have become the leading cause of mortality in India. The epidemiological studies suggest that the ischaemia in cardiac muscle, stroke are the major causes and responsible for >80% of cardiovascular deaths. The Global Burden of disease study estimates of age standardized cardiovascular disease death rate of 272 per 10000 population in India is higher than its global average of 235 per 100000 population. Herbal medicine are also potent medicinal agents like synthetic drugs and are considered to be less toxic and having less side effect in contrast to synthetic drugs. The ultimate norm for any medicine is their specificity, stability, potency, non-toxicity, and efficacy. Terminalia arjuna is one of the most accepted and beneficial plant in indigenous system of medicine. Bark decoction of Terminalia Arjuna is used as a cardioprotective and cardiotonic in angina pectoris, poor blood circulation and for symptomatic relief in high blood pressure.The bark extract contains acids (arjunolic acid, terminic acid), glycosides (arjunetin, arjunosides 1,4) and strong antioxidants flavones, tannins, oligomeric proanthocyanodins. Both of the studies, experimental and clinical, have suggested that the crude drug possesses hypolipidemic, anti-atherogenic activities, anti-ischemic and antioxidant activity. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Sharma; A.; Kumar, D.; Sharma, P. A Review of Terminalia arjuna Effective in Treatment of Cardiovascular Disorders. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 136. DOI: http://doi.org/10.35652/IGJPS.2019.92S34 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.
阿朱末治疗心血管疾病的疗效综述
心血管疾病已成为印度死亡的主要原因。流行病学研究表明,心肌缺血、中风是主要原因,占心血管死亡的80%以上。全球疾病负担研究估计,印度年龄标准化心血管疾病死亡率为每1万人中272人,高于每10万人中235人的全球平均水平。草药也是像合成药物一样的强效药物,与合成药物相比,被认为毒性更小,副作用更小。任何药物的最终标准是其特异性、稳定性、效力、无毒性和有效性。铁蒺藜是我国本土医学体系中公认的有益植物之一。阿朱那树皮煎剂对心绞痛、血液循环不畅、高血压有护心强心作用。树皮提取物含有酸(arjunolic acid, terminic acid),苷(arjunetin, arjunnosides 1,4)和强抗氧化剂黄酮,单宁,低聚原花青素。实验和临床研究均表明,该药材具有降血脂、抗动脉粥样硬化、抗缺血和抗氧化活性。©2019 igglobal研究与出版基金会。版权所有。引用本文如下:Sharma;答:;库马尔,d;arjunia终末草治疗心血管疾病的研究进展。印度国际制药公司。科学。, 2019;9(2生理):136。DOI: http://doi.org/10.35652/IGJPS.2019.92S34。印度全球药物科学杂志(ISSN 2249 1023;CODENIGJPAI;NLM ID: 101610675)在CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index哥白尼,Google Scholar等中索引和摘要。欲了解更多详情,请访问http://iglobaljournal.com这是由APTI赞助,印度旁遮普阿姆利则马纳瓦拉斯里赛药学院组织的“RAPSCON-2019”的特刊。以日志形式提供放松。
本文章由计算机程序翻译,如有差异,请以英文原文为准。